Send the following on WhatsApp
Continue to ChatI liked this article on M3 India: MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): A double-blind, randomised, placebo-controlled, phase 3 trial. Have a read: https://www.m3india.in/contents/journal/mage-a3-immunotherapeutic-as-adjuvant-therapy-for?utm_campaign=unset&utm_medium=share&utm_source=ref_wa